Table 1.
Aggregate Clinical Characteristics of Patients With Visceral Leishmaniasis (VL) and Healthy Endemic Controls (ECs)
| Variables | VL Group (n = 147) | EC Group (n = 134) |
|---|---|---|
| Age, y | ||
| Mean ± SD | 31.60 ± 15.16 | 34.97 ± 11.87 |
| Median | 32 | 33.5 |
| Sex, no. | ||
| Male | 47 | 51 |
| Female | 100 | 83 |
| Illness duration, d | ||
| Mean ± SD | 50.75 ± 56.58 | NA |
| Median | 30 | NA |
| Hemoglobin level, mg/mL | ||
| Before treatment | ||
| Mean ± SD | 8.19 ± 1.72 | ND |
| Median | 8.1 | ND |
| After treatment | ||
| Mean ± SD | 10.30 ± 1.41 | ND |
| Median | 10.2 | ND |
| WBC, ×10 3 cells/mm 3 | ||
| D-0 | ||
| Mean ± SD | 4281.63 ± 1671.23 | ND |
| Median | 4100 | ND |
| D-Dis | ||
| Mean ± SD | 11 094.56 ± 3800.23 | ND |
| Median | 10 500 | ND |
| Splenic enlargement, cm | ||
| D-0 | ||
| Mean ± SD | 4.33 ± 3.25 | NA |
| Median | 3 | NA |
| D-Dis | ||
| Mean ± SD | 0.41 ± 1.09 | NA |
| Median | 0 | NA |
Abbreviations: D-Dis, 28 days after treatment and prior to discharge; D-0, before treatment; NA, not applicable; ND, not done.